Penumbra PEN shares rallied 6.3% in the last trading session to close at $252.23. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.

After the MedTech giant Stryker (NYSE:SYK) agreed to offer $4.9B in cash to acquire Inari Medical (NASDAQ:NARI), a maker of ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Penumbra (PEN – Research Report) yesterday and set a price target of $270.00. The ...

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians.

Penumbra (PEN) is one such stock that our ... Here are three of the most important factors that make the stock of this medical device maker a great growth pick right now. Earnings growth is ...

Our proprietary system currently recommends Penumbra (PEN ... of the most important factors that make the stock of this medical device maker a great growth pick right now. Earnings growth is ...

In a report released on January 6, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Penumbra (PEN – Research Report), with a ...

Earnings growth is arguably the most important factor, as stocks exhibiting exceptionally surging profit levels tend to attract the attention of most investors. And for growth investors, double-digit ...

Investing.com -- Shares of Penumbra, Inc. (NYSE: NYSE:PEN) climbed 8.3% after the announcement that Stryker (NYSE: NYSE:SYK), a prominent player in the medical technology sector, has entered a ...

Investing.com -- Shares of Penumbra, Inc. (NYSE: NYSE:PEN) climbed 8.3% after the announcement that Stryker (NYSE: NYSE:SYK), a prominent player in the medical technology sector, has entered a ...